Drug Design, Biomarkers

    Drug designing is of finding new medications depending upon the biological target. It uses the 3D information about the biomolecules obtained from analytical techniques which is more traceable when there is a high-resolution structure of a target protein bound to a potent ligand to design the drug. Molecular mechanics or molecular dynamics is most often used to estimate the strength of the intermolecular interactions between the molecule and its biological target. Computational methods have geared up in the discovery of a huge number of iterations providing the novel structures.

      Biomarkers include tools and technologies that aid in dynamic and powerful approach to understand the spectrum of neurological diseases in knowing the prediction, cause, diagnosis, progression, regression, or outcome of treatment of a disease.

  • Track 1-1 Ligand-based Drug Design
  • Track 2-2 Structure-based Drug Design
  • Track 3-3 Natural History Markers
  • Track 4-4 Drug Activity Markers
  • Track 5-5 Surrogate/ Diagnostic Biomarkers
  • Track 6-6 Molecular Biomarkers

Related Conference of Genetics & Molecular Biology